Andy Cohen and TRT: How a Regular Patient Would Get Access

What Andy Cohen Has Said About Hormone Therapy

Andy Cohen, the Bravo executive producer and talk show host, has discussed his interest in health optimization and hormone therapy in multiple interviews and on his SiriusXM show Andy Cohen Live. He has referenced using HRT as part of a broader wellness regimen. It is reasonable to infer, based on his public comments, that testosterone replacement is part of that protocol, though he has not disclosed specific drugs, doses, or his prescribing physician.

Why Celebrity Disclosure Matters

When public figures discuss hormone therapy openly, it reduces stigma around a condition that affects roughly 2 out of every 100 men, a prevalence confirmed across large population surveys 1. Male hypogonadism remains underdiagnosed. A 2020 analysis published in The Journal of Urology estimated that fewer than 12% of symptomatic men with low testosterone actually receive treatment 2.

Inference Versus Confirmed Fact

Cohen has not published lab values or named a specific testosterone formulation. Any reference to his protocol in this article is inference based on his public statements. The clinical guidance that follows applies to any adult male pursuing TRT through standard medical channels.

Step 1: Recognizing Symptoms of Low Testosterone

The first barrier to access is recognition. Many men attribute fatigue, low libido, depressed mood, and reduced muscle mass to aging rather than a treatable hormonal deficit. The Endocrine Society's 2018 clinical practice guideline defines male hypogonadism as a total testosterone level below 300 ng/dL measured on at least two morning fasting blood draws, combined with signs or symptoms 3.

Common Symptoms

Symptoms overlap with depression, sleep apnea, and thyroid dysfunction. That overlap is why blood work, not a symptom checklist alone, drives the diagnosis. A 2010 study in the New England Journal of Medicine (N=790) showed that symptoms like low libido and erectile dysfunction correlated most reliably with testosterone levels below 300 ng/dL, while fatigue and depressed mood were less specific 4.

Age-Related Decline Is Real but Gradual

The Baltimore Longitudinal Study of Aging found that total testosterone declines approximately 1 to 2% per year after age 30 5. That trajectory means a man with borderline levels at 40 may cross the clinical threshold by 50. The decline is not inevitable for every individual; obesity, sleep disruption, and chronic illness accelerate it.

Step 2: Getting the Right Lab Work

A physician suspecting hypogonadism will order a fasting morning blood draw (before 10 a.m., when testosterone peaks). The AUA guideline recommends measuring total testosterone first, then free testosterone and sex hormone-binding globulin (SHBG) if total T is borderline (264 to 300 ng/dL) 6.

Required Baseline Labs

Beyond testosterone, the standard pre-TRT panel includes a complete blood count (CBC) with hematocrit, a comprehensive metabolic panel, a lipid panel, prostate-specific antigen (PSA), and luteinizing hormone (LH) plus follicle-stimulating hormone (FSH). LH and FSH distinguish primary hypogonadism (testicular failure, high LH) from secondary hypogonadism (pituitary or hypothalamic origin, low or inappropriately normal LH) 3.

Where to Get Labs

Any commercial lab (Quest Diagnostics, Labcorp) processes these panels. Many telehealth TRT clinics ship at-home lab kits or provide requisition forms for a local draw. Insurance typically covers the blood work when a physician orders it with appropriate ICD-10 coding for symptoms of hypogonadism (E29.1).

Step 3: Choosing a Prescriber and Getting a Prescription

Once labs confirm low testosterone, the next step is finding a prescriber willing to initiate therapy. The 2018 AUA guideline supports TRT for men with unambiguously low testosterone and bothersome symptoms, while advising shared decision-making about risks 6.

In-Person Options

Endocrinologists and urologists are the specialists most experienced with TRT. Primary care physicians can also prescribe testosterone; a 2017 analysis found that PCPs actually write the majority of testosterone prescriptions in the United States 7.

Telehealth Clinics

The growth of telehealth hormone clinics has expanded access dramatically. These platforms typically pair a video consultation with lab review and ship medication directly. Quality varies. Look for clinics that require lab confirmation before prescribing, monitor hematocrit at regular intervals, and have board-certified physicians reviewing each case. The Endocrine Society explicitly warns against prescribing testosterone without biochemical confirmation 3.

Prescription Scheduling

Testosterone is a Schedule III controlled substance under U.S. Federal law. Prescriptions require DEA-registered prescribers and cannot be refilled beyond the limits set by state boards of pharmacy. Most patients receive a 90-day prescription with refills contingent on follow-up lab work.

Step 4: Selecting a Testosterone Formulation

The FDA has approved multiple delivery systems. The choice depends on patient preference, cost, insurance coverage, and adherence patterns.

Injectable Testosterone

Testosterone cypionate and testosterone enanthate are the most prescribed formulations in the U.S. Typical dosing is 100 to 200 mg intramuscularly every 7 to 14 days, or 50 to 100 mg subcutaneously twice weekly for more stable serum levels. A 2014 pharmacokinetic study showed that subcutaneous injections produced comparable testosterone levels to intramuscular injections with fewer peak-trough fluctuations 8.

Generic testosterone cypionate 200 mg/mL (10 mL vial) costs approximately $30, $80 without insurance at most pharmacies. GoodRx and manufacturer discount programs can reduce this further.

Transdermal Gel and Patch

AndroGel (1% and 1.62%) and Testim are brand-name topical gels. They deliver 50 to 100 mg of testosterone daily through the skin. The FDA requires a boxed warning about secondary exposure risk to women and children from skin-to-skin contact 9. Gels cost $200, $500 per month without insurance, though generic formulations have narrowed that gap.

Oral Testosterone

Jatenzo (testosterone undecanoate) gained FDA approval in 2019 as the first oral testosterone replacement that avoids the liver toxicity associated with older 17-alpha-alkylated androgens. The SOAR trial (N=166) demonstrated that 87% of men achieved normal testosterone levels at 90 days 10. Jatenzo typically costs $500+ per month without insurance.

Nasal Testosterone

Natesto is a nasal gel applied three times daily. It has a unique pharmacokinetic profile: short-acting pulses that may preserve hypothalamic-pituitary-gonadal axis function and fertility better than long-acting formulations. A 2019 study found that 90% of Natesto users maintained sperm concentrations above 5 million/mL 11.

Step 5: Monitoring on Therapy

TRT is not a "set it and forget it" prescription. Ongoing lab monitoring is essential for safety.

Hematocrit and Polycythemia Risk

Testosterone stimulates erythropoiesis. The most common adverse effect is polycythemia (hematocrit above 54%), which raises venous thromboembolism risk. The AUA guideline recommends checking hematocrit at 3 months, 6 months, and annually thereafter. If hematocrit exceeds 54%, dose reduction or temporary discontinuation is warranted 6. A 2015 meta-analysis of 51 RCTs (N=3,016) confirmed that injectable testosterone raised polycythemia incidence by 3.2-fold compared to placebo 12.

Cardiovascular Monitoring

The relationship between TRT and cardiovascular events has been debated for a decade. The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, was the first large randomized trial powered for cardiovascular endpoints. It found that testosterone gel did not increase the incidence of major adverse cardiovascular events (MACE) compared to placebo over a median follow-up of 33 months (hazard ratio 0.99, 95% CI 0.81 to 1.21) 13.

PSA and Prostate Health

The 2018 AUA guideline recommends PSA measurement before starting TRT, at 3 to 6 months, and then per standard prostate cancer screening guidelines. TRT is contraindicated in men with known metastatic prostate cancer. For men with treated, low-risk prostate cancer in remission, the Endocrine Society guideline states that TRT can be considered after a shared discussion about uncertainty, typically waiting at least 1 to 2 years post-treatment with undetectable PSA 3.

Bone Density Improvements

The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled trials (N=790 total, all men 65+), showed that one year of testosterone gel significantly increased volumetric bone mineral density of the spine by 7.5% compared to placebo 14. This finding is relevant for older men where hypogonadism overlaps with osteoporosis risk.

Fertility Preservation: A Critical Detour

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing intratesticular testosterone and shutting down spermatogenesis. Men who want to preserve fertility should discuss alternatives before starting TRT.

Clomiphene Citrate and Enclomiphene

Clomiphene citrate (off-label for men) and enclomiphene (its trans-isomer) stimulate endogenous testosterone production by blocking estrogen receptors at the hypothalamus, increasing LH and FSH secretion. A 2015 study of 46 hypogonadal men treated with clomiphene 25 mg every other day showed a mean testosterone increase from 228 ng/dL to 612 ng/dL at 3 months, with preserved or improved sperm parameters 15.

Human Chorionic Gonadotropin (hCG)

HCG mimics LH and can maintain intratesticular testosterone. Some clinicians prescribe hCG 500 to 1,000 IU two to three times weekly alongside testosterone to preserve spermatogenesis. A 2019 review in Fertility and Sterility concluded that combination TRT plus hCG maintained spermatogenesis in 60 to 70% of men, though data remain limited to small case series 16.

Cost and Insurance Reality

The cost of TRT varies dramatically depending on formulation and insurance status.

Generic Injectables Are Affordable

Generic testosterone cypionate is one of the least expensive prescription medications in the U.S. A 10 mL vial of 200 mg/mL (roughly a 10 to 20 week supply depending on dose) costs $30, $80 at retail pharmacies. Syringes and alcohol swabs add approximately $5, $10 per month.

Insurance Coverage Patterns

Most commercial insurers and Medicare Part D cover generic injectable testosterone when prescribed for a confirmed diagnosis of hypogonadism (ICD-10 E29.1) with supporting lab documentation. Prior authorization is common for brand-name products like AndroGel, Jatenzo, and Natesto. A 2021 survey found that 78% of commercially insured men who were prescribed testosterone had their claims approved without appeal 17.

Telehealth Clinic Pricing

Cash-pay telehealth TRT clinics typically charge $100, $250 per month, which bundles consultation, medication, and lab requisitions. This model can be cost-competitive for uninsured patients or those who want faster access without specialist referral wait times.

What Andy Cohen's Access Likely Looks Like Versus Yours

A celebrity based in New York City with access to concierge medicine can get lab results within hours, see an endocrinologist the same week, and have medication delivered overnight. That is not the pathway most patients experience.

The Typical Patient Timeline

For a man walking into a primary care office with symptoms: the first appointment involves a symptom review and lab order. Labs take 1 to 3 days to process. A follow-up visit (in-person or telehealth) to review results occurs 1 to 2 weeks later. If total T is confirmed low on a second draw, the prescription can be written at that visit. From initial appointment to first injection: roughly 3 to 6 weeks.

How to Shorten the Process

Ordering labs before the first physician visit (some telehealth platforms enable this) can cut the timeline to 1 to 2 weeks. Arriving with a prior lab result from a recent physical showing low T also accelerates the diagnostic step.

Long-Term Outcomes on TRT

The TRAVERSE trial's 2023 results were a landmark for long-term safety data. Beyond the primary cardiovascular safety finding, pre-specified secondary analyses showed that testosterone significantly improved sexual function (as measured by the PDQ-Q4 questionnaire) and modestly improved physical function 13.

Mental Health Effects

The TTrials found that testosterone gel improved depressed mood in hypogonadal men 65 and older, as measured by the PHQ-9, though the effect size was modest (mean improvement 2.0 points vs. 0.9 points for placebo, P=0.004) 18. TRT is not a replacement for psychiatric treatment, but it can be a meaningful adjunct when depressive symptoms coincide with confirmed hypogonadism.

Muscle and Body Composition

A 2020 meta-analysis of 35 RCTs (N=5,601) published in JAMA Internal Medicine found that testosterone therapy increased lean body mass by an average of 1.6 kg and decreased fat mass by 1.3 kg compared to placebo over a median treatment duration of 34 weeks 19.

When TRT Is Not the Answer

Not every man with borderline testosterone needs a prescription. The Endocrine Society recommends against TRT in men with the following: breast or prostate cancer, hematocrit above 48% at baseline (relative), uncontrolled heart failure, desire for near-term fertility, or untreated obstructive sleep apnea 3.

Lifestyle Interventions First

Weight loss alone can raise testosterone significantly. A 2013 study in the European Journal of Endocrinology (N=891) found that a 5 to 10% reduction in body weight increased total testosterone by approximately 50 ng/dL in obese men 20. Sleep optimization, resistance training, and reducing alcohol intake also contribute to endogenous testosterone recovery.

For men confirmed to have organic hypogonadism (Klinefelter syndrome, pituitary tumors, bilateral orchiectomy), lifestyle interventions alone will not restore normal testosterone. TRT is the standard of care, and monitoring with hematocrit and PSA checks at 3 and 6 months post-initiation remains non-negotiable per the AUA and Endocrine Society guidelines 3, 6.